Companies: 10,795·Total market cap: $144.5T
Cerus Corporation

Cerus Corporation

CERSNASDAQHealthcare● Active
$2.60
$-0.11(-4.06%)
Market Cap$520959332
P/E Ratio
52W High$3.15
52W Low$1.15

Cerus Corporation(CERS)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · CERS · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.21B$0.18B$0.16B$0.16B$0.13B
Cost of Revenue$0.10B$0.08B$0.07B$0.07B$0.06B
Gross Profit$0.11B$0.10B$0.09B$0.09B$0.07B
Gross Margin %(computed)53.50%55.21%55.25%53.75%51.49%
Operating Expenses
R&D Expenses$0.07B$0.06B$0.07B$0.06B$0.06B
G&A Expenses$0.00B$0.00B$0.00B$0.00B$0.00B
Total Operating Expenses$0.15B$0.11B$0.12B$0.12B$0.12B
Operating Income($0.04B)($0.01B)($0.03B)($0.03B)($0.05B)
Operating Margin %(computed)-17.63%-7.89%-19.22%-21.03%-37.40%
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.01B$0.01B$0.01B$0.01B$0.00B
Income Before Tax($0.02B)($0.02B)($0.04B)($0.04B)($0.05B)
Income Tax Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Net Income($0.02B)($0.02B)($0.04B)($0.04B)($0.05B)
Net Margin %(computed)-7.58%-11.60%-23.98%-26.40%-41.55%
Per Share & EBITDA
EPS (Basic)$-0.08$-0.11$-0.21$-0.24$-0.32
Wtd Avg Shares0.19B0.18B0.18B0.18B0.17B
EBITDA($0.03B)($0.01B)($0.03B)($0.03B)($0.05B)
EBITDA Margin %(computed)-16.66%-5.56%-16.84%-20.69%-35.14%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Cerus Corporation

关于Cerus Corporation(CERS)损益表

Cerus Corporation(CERS)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,CERS实现营收$0.21B,毛利润$0.11B(毛利率53.50%),净利润($0.02B)(净利率-7.58%)。

常见问题

CERS · 4 问

Cerus Corporation(CERS)2025财年营收为$0.21B,同比up14.3%。

CERS revenueCERS salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08